|Bid||80.00 x 800|
|Ask||106.27 x 1200|
|Day's Range||91.69 - 93.58|
|52 Week Range||71.90 - 106.27|
|PE Ratio (TTM)||24.16|
|Earnings Date||Aug 1, 2018 - Aug 6, 2018|
|Forward Dividend & Yield||1.52 (1.60%)|
|1y Target Est||102.87|
At the Berkshire Hathaway annual shareholder meeting, Warren Buffett and Charlie Munger discuss health care and finding a better way to provide it.
Gains were broad based as seven out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Services stocks: GNC Holdings Inc. (NYSE: GNC), Rite Aid Corp. (NYSE: RAD), Walgreens Boots Alliance Inc. (NASDAQ: WBA), and AmerisourceBergen Corp. (NYSE: ABC).
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Consumer Services sector is rising.
With an ROE of 25.26%, AmerisourceBergen Corporation (NYSE:ABC) outpaced its own industry which delivered a less exciting 13.80% over the past year. On the surface, this looks fantastic since weRead More...
In a much-anticipated decision, the largest public company in Greater Philadelphia chooses Conshohocken as its new corporate home.
Under federal pressure to tighten the pharmaceutical supply chain and keep drugs from falling into the wrong hands, drug companies are ramping up experiments with promising but unproven blockchain technologies. AmerisourceBergen Corp. and Merck & Co. Inc. plan to expand a test project completed last year that tracked the ownership of drugs moving through the health-care supply chain. The new test will increase the number of drugs and health-care devices and perform more complex transactions, said Dale Danilewitz, chief information officer at the drug distributor.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Recent efforts to expand their footprints have impacted Walgreens (WBA) and CVS Health’s (CVS) share prices. CVS has faced investors’ skepticism about its plans to acquire Aetna.
Drugstore stocks have been under pressure in the past year due to fears of Amazon (AMZN) entering the pharma space, President Trump’s drug pricing policy change, and the ongoing consolidation wave in the industry.
The county is seeking unspecified damaged. Among the opioid epidemic-related costs Bucks County claims to have incurred is a $20 million prison expansion project.
The region is now home to 14 members of the annual list of the 500 highest grossing U.S. companies, with another 13 being ranked between No. 501 and No. 1000.
The FDA released a list of drugmakers it said are getting in the way of generic drug development. Stocks of pharmacy benefit managers and biotech companies still outperformed the market. The biopharma and drug supply chain sectors outperformed the market last week, even as Trump administration officials pressed the president's blueprint to lower drug prices, with tough rhetoric for drugmakers and public shaming of pharmaceutical firms for supposedly blocking competition.
Big Pharma and biotech stocks popped Friday after a drug-pricing speech from President Trump was consistent with views that he would offer "more rhetoric than reform."
WASHINGTON—Prescription-drug wholesalers that for years shipped hundreds of opioid pills per person to small towns in West Virginia mostly denied they were a cause of surging addiction as lawmakers grilled them on Tuesday. Most company executives told a House hearing that their companies’ actions didn’t fan the opioid epidemic in the state. Only one executive, Joseph Mastandrea, chairman of Miami-Luken Inc. said that his company had a “shared responsibility” for the opioid crisis.
and H.D. Smith Wholesale Drug Company told the House Committee on Energy and Commerce their companies did not contribute to the opioids epidemic. The five drug distribution companies were ordered to appear before the committee on Tuesday, May 8. Since last May the committee has been investigating the number of opioid pills that were shipped to West Virginia.
George Barrett, executive chairman and past CEO of Cardinal Health Inc., apologized before a Congressional committee investigating the role of drug distributors in sending millions of doses of opioids to questionable pharmacies, particularly two in rural West Virginia. Barrett explained today's procedures would have blocked the shipments.
President Donald Trump is expected to outline new policies to deliver on his pledge to bring prices down in a speech that could come this week. The need to bring down high drug prices may be one of the few health care issues that draw bipartisan support in Washington and on Main Street.
Assessing AmerisourceBergen Corporation’s (NYSE:ABC) performance as a company requires looking at more than just a years’ earnings data. Below, I will run you through a simple sense check to buildRead More...
Drug distributor AmerisourceBergen Corp posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent. The company has spent about $22 million since the beginning of the year to fix problems at the facility, Chief Financial Officer Tim Guttman said on a conference call, adding any income contribution this year is expected to be nominal. The Memphis plant was acquired as part of a 2015 buy of PharMEDium Healthcare Holdings and has remained closed since December following inspections by the U.S. Food and Drug Administration.
AmerisourceBergen Corp. shares rose 2.2% in premarket trade Wednesday after the company reported second-quarter profit and revenue beats. Adjusted earnings-per-share came to $1.94, above the FactSet consensus of $1.82. Revenue rose to $41.03 billion from $37.15 billion, above the FactSet consensus of $40.55 billion.
The Chesterbrook, Pennsylvania-based company said it had profit of $1.29 per share. Earnings, adjusted for one-time gains and costs, came to $1.94 per share. The results exceeded Wall Street expectations. ...